Development of an in vitro keratinocyte model for use in the study of HSV specific cytotoxicity.
Herpes simplex virus (HSV) specific immune mediated cytotoxicity may be involved in control of HSV infections and in the tissue damage induced by HSV infection or HSV related skin disease such as herpes associated erythema multiforme. Developing an in vitro model to study this process has proved difficult due to the lack of an appropriate target cell that will express HSV antigens but is not simultaneously subject to viral induced cell death. The purpose of this study was to develop a model in which keratinocytes express cell surface HSV specific antigens but at the same time are protected from death due to viral infection. We found that keratinocytes infected with HSV in the presence of acyclovir (ACV) expressed such antigens yet remained viable for a period of time after the onset of antigen expression such that cytotoxicity studies could be successfully performed. Rabbit skin cells, a transformed keratinocyte line, or second passage human neonatal foreskin keratinocytes were grown in culture medium with or without 200 microM ACV and were infected with HSV. Examination by direct immunofluorescence with anti-HSV antibody revealed uniform HSV antigen expression by cells both with and without ACV by 8 h after infection. Cells infected without ACV exhibited marked structural abnormalities including formation of multinucleated giant cells, while cells with ACV showed fewer such changes throughout a 24-h period. An Ethidium Bromide-Acridine Orange cytotoxicity assay demonstrated significant increases in the cytotoxicity of infected cells not protected by ACV compared to that of cells with ACV (p less than .001). This in vitro model should prove useful in the investigation of HSV specific immune mediated cytotoxicity.
D000165:Acridine Orange; D000212:Acyclovir / Q000494:pharmacology; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic; D000078404:Epidermal Cells; D004817:Epidermis / Q000276:immunology; D000939:Epitopes; D004996:Ethidium; D006561:Herpes Simplex / Q000276:immunology / Q000473:pathology; D007633:Keratins / Q000276:immunology; D018139:Simplexvirus / Q000276:immunology*
D000956:Antigens, Viral; D000939:Epitopes; D007633:Keratins; D004996:Ethidium; D000165:Acridine Orange; D000212:Acyclovir